Journée scientifique 2017

26th ARTP Annual Meeting - 15 November 2017
30 years of progress in Prostate Cancer: OligoClonal Heterogeneity, Precise Molecular Therapeutic Innovation and Theranostic

Palais des Congrès de Paris - 2 place de la Porte Maillot - 75017 Paris

Téléchargez le programme sous format PDF

Téléchargez le coupon d'inscription (les inscriptions sont closes depuis le 25 octobre 2017)

Téléchargez les indications pour votre poster (les soumissions de poster sont closes depuis le 3 novembre 2017)

Téléchargez le plan d'accès au Palais des Congrès

8:15 a.m.
Registration at the ARTP Registration Desk (3rd floor)

8:55 a.m.
Welcome Pr Alexandre de la Taille, ARTP President

9:00 a.m.
Session I : Stem Cells & Neuroendocrine Cells
Chairs : Pr Laurent Morel, Dr Vincent Goffin

Speakers : 
Pr Norman Maitland (York University, Heslington, UK) 
'Modelling of stem cell fate and differentiation using tissue-derived human prostate epithelial cells'
Dr David Goodrich (Roswell Park Center Institute, Buffalo, USA) 
'Lineage plasticity and antiandrogen resistance in prostate cancers'
Dr David Rickman (Weill Cornell Medical College, NY, USA)
'Transcriptional Program Driving Neuroendocrine Prostate Cancer'

 

10:30 a.m.
Coffee break

10:45 a.m.
Session II : Oligometastatic Cancers
Chairs : Dr Olivier Cuvillier, Dr Daniel Metzger

Speakers : 
Dr Christopher Sweeney (Dana-Farber Cancer Institute, Boston, USA) 
'Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations'
Dr Bertrand Tombal (Clinique Universitaire Saint-Luc, Bruxelles, Belgique)
‘Oligometastatic prostate cancer: Metastases-directed therapy?’

11:45 a.m.
30 years of ARTP
Pr Alexandre de la Taille, ARTP President
Dr Dominique Authié, Pierre Fabre Médicament

 


12:00 a.m. 
Lunch Restaurant Tower Sports Bar (Level 4 Hyatt Hotel)

1:30 p.m.
Session III : Translational and Clinical Session: Theranostics
Chairs : Dr Palma Rocchi, Dr Jocelyn Ceraline

Speakers : 
Dr Karolien Goffin (Katholieke Universiteit, Leuven, Belgium)
'Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations'
Dr Monique Bernsen (Erasmus MC, Rotterdam, Netherlands)
'Towards Personalized Treatment of Prostate Cancer: PSMA, a Promising Prostate- Specific Membrane Antigen-Targeted Theranostic Agent' 

2:30 p.m.
Session IV : ESUR/ARTP Laureates
Moderators : Dr Virginie Vlaeminck, Dr Edith Bonnelye

Speakers : 
Dr Domenico Albino (Institute of Oncology Research, Bellinzona, Switzerland)
‘ESE3/EHF controls the Lin28/let-7 microRNA axis to restrain cell transformation and cancer stem-like compartment in prostate cancer’
Dr Daniel Metzger (Inserm U964/CNRS UMR7104, Strasbourg) 
‘Impact of Vitamin D analogs on prostatic intra-epithelial neoplasia in the mouse’
Pr Laurent Guy (EA 4677, Clermont-Ferrand) 
‘Régulation de la marque H3K27me3 par la déméthylase JMJD3 et la méthyltransférase EZh3 dans les cancers de la prostate’
Dr Yamina Hamma-Kourbali (Inserm U955, Créteil)
‘NRP1 Promotes Neuroendocrine Prostate Cancer Initiation and Therapeutic Resistance through regulation of PKC Pathway’
Dr Silvère Baron (Inserm U1103/CNRS UMR6293, Clermont-Ferrand)
‘Androgen Receptor and Liver X Receptors network in prostate cancer'

4:00 p.m.
Session V : Poster Session
Chairs : Dr Palma Rocchi, Dr Jocelyn Ceraline
Selection Committee : Virginie Vlaeminck, Edith Bonnelye, Laurent Morel, Vincent Goffin, Dimitra Gkika, Stéphane Terry

5:00 p.m.
Session VI : 2016 ARTP Poster Prize Laureates
Chairs : Dr Stéphane Terry, Dr Dimitra Gkika

Speaker :
Sandy Figiel (Inserm U1069, Tours) 
‘PUFA are associated with prostate cancer aggressiveness and involved in EMT’

5:15 p.m.
ARTP General Assembly
Pr Alexandre de la Taille, ARTP President
Dr Olivier Cuvillier, ARTP Treasurer
Poster Prize distribution

5:45 p.m.
Closing Remarks
Pr Alexandre de la Taille, ARTP President

 

Sponsors de la Journée SCIENTIFIQUE de l'ARTP 2017